コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 xamine the association of AUD with workplace absenteeism.
2 ed to assess the association between AUD and absenteeism.
3 t the ability to perform at work and lead to absenteeism.
4 for school-aged children may prevent school absenteeism.
5 nstruction was not associated with increased absenteeism.
6 tion between SBHC access and risk of chronic absenteeism.
7 Primary outcome was days of unplanned absenteeism.
8 avy menstrual bleeding or pain contribute to absenteeism.
9 l exhaustion, and professional efficacy) and absenteeism.
10 as no significant effect of BCG on unplanned absenteeism.
11 on a network in the context of rising worker absenteeism.
12 ion in susceptibility and access to sickness absenteeism.
13 on symptom presentation, social history, and absenteeism.
14 ty, healthcare seeking, hospitalization, and absenteeism.
15 pressure on quality of life, mood, and work absenteeism.
16 c impacts resulting from hospitalization and absenteeism.
17 ure of asthma-associated morbidity is school absenteeism.
18 t presentation to the school nurse or during absenteeism.
19 of SLV on laboratory-confirmed influenza and absenteeism.
20 ovements in management methods reduce school absenteeism.
21 nt-perceived ill health, and school problems/absenteeism.
22 levels of health care utilization, and work absenteeism.
23 care use and indirect costs, chiefly through absenteeism.
24 as chronically absent or at risk for chronic absenteeism.
25 sease and hospitalization, leading to school absenteeism.
26 children with 2 or more conditions, had more absenteeism (1 condition adjusted incidence rate ratio [
28 ng those employed, the mean score was 2% for absenteeism, 18% for presenteeism, and 19.6% for overall
29 .5%; adjusted OR, 1.25 [95% CI, 1.09-1.43]), absenteeism (26.0% vs 20.9%; adjusted OR, 1.23 [95% CI,
30 p = 0.01), and nonsignificantly reduced work absenteeism (-3.35 [-6.83, 0.14], p = 0.06); partnered I
31 nge from baseline [SE]) relative to placebo: absenteeism (-3.5 [0.87], P < .001; -2.6 [0.84], P = .00
33 t risk (0%-4.99% absent), at risk of chronic absenteeism (5%-9.99% absent), and chronically absent (>
35 .006 to 0.03] L/yr, respectively), and lower absenteeism (-8% [95% CI, -16.0 to -0.7%]), with stronge
36 the relative prevalence of menstrual-related absenteeism across different levels of the independent v
37 nd factors contributing to menstrual-related absenteeism across low-income and middle-income countrie
38 reater odds of being not at risk for chronic absenteeism after accounting for grade, sex, school year
39 hildren looked after away from home had less absenteeism (AIRR 0.35, 95% CI 0.33 to 0.36), less exclu
40 gnificant morbidity and high rates of school absenteeism, along with excessive costs for the patient
41 95% CrI, 2 524 351-3 332 783) days of school absenteeism among children aged 5 to 17 years and an est
42 ed with increased respiratory-related school absenteeism among children, especially those with asthma
43 on was found between SBHC access and reduced absenteeism among elementary school students and among c
44 of nosocomial spread of COVID infection and absenteeism among healthcare workers, impacting the qual
47 -level data, I show that the rate of chronic absenteeism among US public-school students grew substan
48 ght leads to over a 50% increase in employee absenteeism and a reduction of more than two working hou
49 itive employees and associated reductions in absenteeism and benefit payments lead to cost savings co
50 sting depression was the strongest driver of absenteeism and coexisting ADHD the strongest driver of
51 probably associated with increases in school absenteeism and dropout; reduced likelihood of obtaining
52 of SEN and 9.53, 12.70, and 13.74 years for absenteeism and exclusion, attainment, and unemployment,
53 rbidity was associated with increased school absenteeism and exclusion, unemployment, and poorer exam
55 truction, and asthma-related school and work absenteeism and hospital admissions obtained during nine
56 was no association between menstrual-related absenteeism and household wealth or the use of menstrual
57 mentation, alone or in combination, affected absenteeism and illness in iron-deficient schoolchildren
61 , we emphasize the biasing influence of data absenteeism and positionality and conclude with recommen
63 MTX, CZP plus MTX significantly reduced work absenteeism and presenteeism among patients working outs
64 nts with CHC GT1 in the ION trials exhibited absenteeism and presenteeism impairments of 2.57% and 7.
65 rials achieved SVR; these patients exhibited absenteeism and presenteeism impairments of 2.62% (P = 0
66 pulation; standardized absolute and relative absenteeism and presenteeism scores; standardized scores
67 euro55 and euro151 billion per annum due to absenteeism and presenteeism, that is, euro2405 per untr
72 udent influenza vaccination coverage, school absenteeism, and community-wide indirect effects on labo
77 ed spending on treatment, wage losses due to absenteeism, and reductions in quality of life, for indi
78 infection, incidence of infection-associated absenteeism, and scores on the physical and mental healt
80 chronotype on grades was similar to that of absenteeism, and that late chronotypes were more often a
81 fectiveness, vaccine coverage, risk factors, absenteeism, and use of personal protective equipment, a
83 itive to assumptions regarding incidence and absenteeism, ART is cost-saving under considerable param
84 Primary outcomes were markers of workplace absenteeism as defined by the number of days missed from
85 lementation should reduce significant school absenteeism as well as complications seen last year incl
87 d 0 to 17 years and estimated days of school absenteeism averted among children aged 5 to 17 years un
88 and wellbeing (increased accidents, fatigue, absenteeism) but can be perceived as beneficial by both
89 sociated with improved FeNO, FVC growth, and absenteeism, but these findings were primarily restricte
92 ion of historical metrics including those on absenteeism, caseload, and competence, which primarily c
93 and classified by federal and state chronic absenteeism categories: not at risk (0%-4.99% absent), a
101 enza vaccination was associated with reduced absenteeism due to fever or cough illness, but not absen
102 The vaccine efficacy for preventing school absenteeism due to respiratory illness during the period
107 he outcome of interest was menstrual-related absenteeism from work, school, or social activities duri
113 ed symptoms of infection, symptom-associated absenteeism, health care use, and impact on daily activi
114 e, asthma status, and illness-related school absenteeism in a cohort of 1,932 fourth-grade schoolchil
115 f participant-reported infection and related absenteeism in a sample of participants with type 2 diab
116 r job security was associated with decreased absenteeism in the past year (IRR, 0.89 [95% CI, 0.82-0.
118 vel COVID-19 cases, quarantines, and student absenteeism, increasing missingness over time, and varia
119 h SEN (OR 1.28, CI 1.18 to 1.39, p < 0.001), absenteeism (IRR 1.09, CI 1.06 to 1.12, p < 0.001), excl
122 eading cause of school absenteeism, but this absenteeism is not equally distributed among those with
125 oductive capacity (99% vs 87%; P<.001), less absenteeism (losses = $24 vs $115 per worker per month;
127 cancer was adversely associated with school absenteeism, medical care unaffordability, health care u
129 , parental cancer was associated with school absenteeism, medical care unaffordability, increased hea
130 ing implied by the sharp increase in chronic absenteeism merit further scrutiny and policy responses.
131 o which AUD currently factors into workplace absenteeism needs further characterization in the US.
133 eventing daily activities, resulting in work absenteeism or requiring medical consultation (adjusted
136 prevented daily activities, resulted in work absenteeism, or required a medical consultation, includi
137 an increased prevalence of menstrual-related absenteeism (overall pooled prevalence ratio 1.25 [1.05-
138 omic consequences such as absence from work (absenteeism), particularly reduced productivity at work
140 relevant publications reporting outcomes on absenteeism, presenteeism and productivity losses in mod
143 SUDs have a diagnosis, and costs related to absenteeism, presenteeism, job retention, and mortality
144 ts, hospitalizations in the past six months; absenteeism, presenteeism, overall work impairment, and
151 ion during the COVID-19 pandemic had chronic absenteeism rates that were 6.9 percentage points (95% C
152 ) in influenza hospitalization incidence and absenteeism rates using generalized linear and log-linea
153 on much larger for at-risk students; chronic absenteeism rates were 10.6 percentage points (95% CI, 7
156 ctiveness in schools have assessed all-cause absenteeism rather than laboratory-confirmed influenza.
161 ave a higher prevalence of menstrual-related absenteeism than those in older age groups, with overall
162 xperienced a 22% absolute decrease in school absenteeism, the number of children with an Asthma Contr
163 re less sensitive to the value of the excess absenteeism threshold triggering the start of the interv
164 from generalized discomfort and work-related absenteeism to emergency department visits from patients
165 ciation between virtual learning and chronic absenteeism varied by socioeconomic status, with the con
166 erall pooled prevalence of menstrual-related absenteeism was 15.0% (95% CI 12.7-17.3), with prevalenc
167 was 20.5 points; percent reductions in WPAI absenteeism was 34.4%, presenteeism 26.8%, overall work
172 st (13.0 days) and the rate of parental work absenteeism was highest (136 days per 100 children with
176 oxide (FeNO), lung function (FEV1, FVC), and absenteeism were also collected monthly (1,768 visits).
177 ns between each factor and menstrual-related absenteeism were analysed using log-binomial models.
182 ed with an increased prevalence of workplace absenteeism, with individuals with AUD contributing over